CymaBay Therapeutics Inc

NAS:CBAY (USA)  
$ 32.48 +0.01 (+0.03%) 11:08 PM EST
At Loss
P/B:
12.63
Volume:
2.73M
Avg Vol (2M):
4.71M
Also Trade In:
Volume:
2.73M
At Loss
Avg Vol (2M):
4.71M

Business Description

Description
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in pipeline includes two clinical stage product candidates: seladelpar (a PPARd agonist) and MBX-2982 (a GPR119 agonist).
Name Current Vs Industry Vs History
Cash-To-Debt 3.44
Equity-to-Asset 0.67
Debt-to-Equity 0.39
Debt-to-EBITDA -1.34
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.97
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 81.79
9-Day RSI 83.84
14-Day RSI 81.14
6-1 Month Momentum % 101.76
12-1 Month Momentum % 235.56

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.96
Quick Ratio 10.96
Cash Ratio 10.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.2
Shareholder Yield % -9.49

Financials (Next Earnings Date:2024-05-15 Est.)

CBAY's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CBAY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CymaBay Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 31.073
EPS (TTM) ($) -0.99
Beta -0.03
Volatility % 47.65
14-Day RSI 81.14
14-Day ATR ($) 0.313974
20-Day SMA ($) 32.30575
12-1 Month Momentum % 235.56
52-Week Range ($) 7.2609 - 32.48
Shares Outstanding (Mil) 114.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CymaBay Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

CymaBay Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

CymaBay Therapeutics Inc Frequently Asked Questions

What is CymaBay Therapeutics Inc(CBAY)'s stock price today?
The current price of CBAY is $32.48. The 52 week high of CBAY is $32.48 and 52 week low is $7.26.
When is next earnings date of CymaBay Therapeutics Inc(CBAY)?
The next earnings date of CymaBay Therapeutics Inc(CBAY) is 2024-05-15 Est..
Does CymaBay Therapeutics Inc(CBAY) pay dividends? If so, how much?
CymaBay Therapeutics Inc(CBAY) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1